Samuel Levy has joined the genomic medicine program of Scripps Health as director of genomic sciences. He joins Scripps from the J. Craig Venter Institute in Rockville, Md., where he was director and professor of human genomics.
Previously, he was a senior scientist and lead informatics researcher at Celera, where he was involved in developing computational tools for gene discovery for the company's human genome project. Before that, he was an independent investigator in the Molecular, Cellular and Developmental Biology Department at the University of Colorado at Boulder and at École Normale Supérieure in Paris.
Levy holds a PhD in cell and computational biology from the University of Bristol, and a bachelor's degree in molecular biophysics from the University of Leeds, both in the UK.
At Scripps, he will be based at the Scripps Translational Science Institute, where he will direct the institute's human genome sequencing efforts. He will also assist in building a high-throughput computing infrastructure for the analysis of DNA sequence data. In addition, Levy will direct STSI's integrated genomics program, which fosters collaborations between research teams in the San Diego region, including the JCVI.
George Church has been elected as a director of Sigma-Aldrich. He is a professor of genetics at Harvard Medical School and director of the Center for Computational Genetics.
Robert Carroll has joined Sensorin, a Burlingame, Calif.-based company developing a self-calibrating pH measurement platform, as vice president of operations and manufacturing, after serving as an advisor to the company.
Over the last eight years, he has consulted for more than 20 emerging technology companies. Prior to that, he was vice president for materials and manufacturing operations at Affymetrix, and before that, he was vice president for site operations and later director of worldwide distribution and division vice president for Applied Biosystems.
Carroll holds a BS in electrical engineering from the Case Institute of Technology.